Technical Analysis for RGEN - Repligen Corporation

Grade Last Price % Change Price Change
A 214.48 -3.27% -7.25
RGEN closed up 4.4 percent on Monday, March 1, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical RGEN trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -3.27%
Inside Day Range Contraction 0.98%
Fell Below 20 DMA Bearish 3.58%
50 DMA Support Bullish 3.58%
Outside Day Range Expansion 3.58%
Crossed Above 20 DMA Bullish -0.51%
Pocket Pivot Bullish Swing Setup -0.51%
Doji - Bearish? Reversal -0.51%
Gapped Up Strength -0.51%
50 DMA Support Bullish 3.86%
Older End-of-Day Signals for RGEN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Outside Day 11 minutes ago
Fell Below Previous Day's Low 11 minutes ago
Down 3% about 1 hour ago
60 Minute Opening Range Breakdown about 2 hours ago
Down 2 % about 2 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Repligen Corporation Description

Repligen Corporation, a life sciences company, engages in the development, production, and commercialization of consumable products used in the process of manufacturing biological drugs. Its bioprocessing products are sold to various life sciences and biopharmaceutical companies worldwide. The company manufactures Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. It also supplies various growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, the company develops and markets its OPUS brand series of pre-packed ‘plug-and-play' chromatography columns, and provides ELISA test kits to ensure final product quality. Further, Repligen has a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and a orphan drug candidate in Phase 1 development. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Natural Sciences IBD 50 Monoclonal Antibody Consumable Products 3 D Chromatography Imaging Agent Orphan Drug Bioprocessing Cell Culture Chromatography Column Bioprocess Growth Factor Products

Is RGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 228.835
52 Week Low 78.41
Average Volume 372,216
200-Day Moving Average 165.66
50-Day Moving Average 206.80
20-Day Moving Average 216.03
10-Day Moving Average 214.07
Average True Range 9.38
ADX 15.24
+DI 26.84
-DI 27.58
Chandelier Exit (Long, 3 ATRs ) 200.69
Chandelier Exit (Short, 3 ATRs ) 215.50
Upper Bollinger Band 226.94
Lower Bollinger Band 205.12
Percent B (%b) 0.76
BandWidth 10.10
MACD Line 1.91
MACD Signal Line 2.71
MACD Histogram -0.7976
Fundamentals Value
Market Cap 11.67 Billion
Num Shares 52.6 Million
EPS 0.83
Price-to-Earnings (P/E) Ratio 268.76
Price-to-Sales 30.43
Price-to-Book 8.75
PEG Ratio 2.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 234.09
Resistance 3 (R3) 232.89 227.57 232.03
Resistance 2 (R2) 227.57 224.42 228.17 231.34
Resistance 1 (R1) 224.65 222.48 226.11 225.85 230.66
Pivot Point 219.33 219.33 220.06 219.93 219.33
Support 1 (S1) 216.41 216.18 217.87 217.61 212.80
Support 2 (S2) 211.09 214.24 211.69 212.12
Support 3 (S3) 208.17 211.09 211.43
Support 4 (S4) 209.37